| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.lasalabs.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 293.25 Cr. | |
| Earnings per share (EPS) | 5.60 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 12.87 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 32.74 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 39.07 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 1.85 | Calculated using Price: 72.10 |
| Dividend Yield | 0.35 | Period Ending 2020-03 |
| No. of Shares Subscribed | 4.07 Cr. | 40,672,668 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Lasa Supergenerics (Lasa) is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012. The manufacturing base of Lasa group is located at Mahad, in the Konkan region of Maharashtra. It specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India. To efficiently control the supply chain, the group backward integrated its key molecules-from discovery research up to full-scale bulk production. Lasa group’s marketing footprint is entrenched across developing markets in multiple countries. Similarly, the group expects to augment its export footprint significantly in width and depth in the future. The group has alliances with leading Indian and global animal health care conglomerates, and uses Good Manufacturing Practice (GMP) and world-class technologies in its operations. Business area of the company The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India Product Categories
|
||
Company Profile
Lasa Supergenerics (Lasa) is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012. The manufacturing base of Lasa group is located at Mahad, in the Konkan region of Maharashtra. It specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India. To efficiently control the supply chain, the group backward integrated its key molecules-from discovery research up to full-scale bulk production.
Lasa group’s marketing footprint is entrenched across developing markets in multiple countries. Similarly, the group expects to augment its export footprint significantly in width and depth in the future. The group has alliances with leading Indian and global animal health care conglomerates, and uses Good Manufacturing Practice (GMP) and world-class technologies in its operations.
Business area of the company
The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India
Product Categories
| 1 Day |
|
-2.58% |
| 1 Week |
|
-3.43% |
| 1 Month |
|
-12.97% |
| 3 Month |
|
-7.12% |
| 6 Month |
|
-9.86% |
| 1 Year |
|
+22.95% |
| 2 Year |
|
+620.16% |
| 5 Year |
|
| 5 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 8.65 | 14.33 | -10.81 | 2.94 | ||
| Return on Capital Employed (%) | 14.45 | 12.80 | -3.73 | 6.77 | ||
| Return on Assets (%) | 2.07 | 4.79 | -4.44 | 1.50 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 0 | 75 | 117 | 105 | 141 | |
| Non Curr. Liab. | 0 | 83 | 62 | 43 | 11 | |
| Curr. Liab. | 70 | 107 | 107 | 76 | ||
| Minority Int. | ||||||
| Equity & Liab. | 0 | 228 | 287 | 255 | 229 | |
| Non Curr. Assets | 149 | 178 | 170 | 153 | ||
| Curr. Assets | 0 | 79 | 109 | 86 | 76 | |
| Misc. Exp. not W/O | 0 | |||||
| Total Assets | 0 | 228 | 287 | 255 | 229 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 199 | 244 | 170 | 167 | ||
| Other Income | 2 | 3 | 1 | 0 | ||
| Total Income | 201 | 247 | 170 | 167 | ||
| Total Expenditure | -153 | -202 | -159 | -137 | ||
| PBIDT | 48 | 45 | 12 | 30 | ||
| Interest | -12 | -11 | -8 | -8 | ||
| Depreciation | -8 | -18 | -19 | -17 | ||
| Taxation | 0 | -3 | 4 | -1 | ||
| Exceptional Items | -26 | |||||
| PAT | 2 | 12 | -12 | 4 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -3 | 40 | 41 | 14 | |
| Cash Fr. Inv. | 0 | -44 | -7 | -2 | ||
| Cash Fr. Finan. | 0 | 0 | 4 | -33 | -10 | |
| Net Change | 0 | -3 | 0 | 0 | 2 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 3 |
|
Thu, 05 Aug 2021
Certificate Of Non-Disqualification Of Directors Under Regulation 34(3) Of SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial<BR> Year Ended March 31 2021. In pursuant to Regulation 34(3) and Schedule V Para C clause (10) (i) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Certificate of Non Disqualification of Directors for the Financial Year Ended on 31 March 2021 issued by M/s. Shivam Sharma & Associates. Practicing Company Secretaries Secretarial Auditors of the Company dated August 04 2021. |
|
Mon, 26 Jul 2021
Announcement under Regulation 30 (LODR)-Press Release / Media Release Attached is a copy of Press Release tilted No Casualty in any of companys units. Production to recommence in couple of Weeks. Issued by the company. |
|
Fri, 23 Jul 2021
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances Pursuant to the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and the Circular Ref no. CIWCFDICMD/4/2015 dated September 09 2015 issued by SEBI we wish to inform you that fire accident occurred today in our Plant situated at Mahad Dist raigad and also heavy rains in the Konkan region has disrupted all operations in all Units situated at Chiplun. The rains which lashed the city led to water logging and inflow of water into factory premises resulting in some damage to inventory and Machineries. |
| Wed, 04 Aug 2021 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Close Crossing Last Month Close from Above
|
Closing Below Previous Low
|
Equities
M.F.
Sectors